Human medicines European public assessment report (EPAR): Symtuza, darunavir,cobicistat,emtricitabine,tenofovir alafenamide, Date of authorisation: 21/09/2017, Revision: 18, Status: Authorised

Chemistry of active substances (chemistry of new active substances) - Scientific guideline

Draft guideline on the chemistry of active substances - Revision 1

Human medicines European public assessment report (EPAR): Byfavo, remimazolam, Date of authorisation: 26/03/2021, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Nulibry, fosdenopterin, Date of authorisation: 15/09/2022, Revision: 3, Status: Authorised

Opinion/decision on a Paediatric investigation plan (PIP): Prevymis, Letermovir, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0455/2023

EMEA-000737-PIP02-11-M03

Vabysmo

Human medicines European public assessment report (EPAR): Entecavir Accord, entecavir, Date of authorisation: 25/09/2017, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Mozobil, plerixafor, Date of authorisation: 30/07/2009, Revision: 25, Status: Authorised